ECT2 and breast carcinoma: For example, ECT2 is reported to be involved in cancer development, influencing processes such as the cell cycle, apoptosis and cell division [60]; FABP4 is involved in the activation of the immune response and is reported to be related to breast cancer [61] and bladder cancer [62]; and TOP2A is involved in stomach cancer [51].